The 2011 Import and Export Market for Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and Streptomycins in New Zealand by ICONGroup

VIEWS: 0 PAGES: 42

More Info
									  The 2011 Import and Export
    Market for Medicaments
   Containing Antibiotics in
     Dosage Form or Retail
 Packings Excluding Penicillins
   and Streptomycins in New
            Zealand




www.icongrouponline.com   ©2011 ICON Group Ltd.
                                         By
                         Professor Philip M. Parker, Ph. D.
                      Chaired Professor of Management Science
                    INSEAD (Singapore & Fontainebleau, France)




www.icongrouponline.com                                      ©2011 ICON Group Ltd.
                                                                                                                  iii




                                             COPYRIGHT NOTICE
                                                00037779-8G


All of ICON Group Ltd. publications are copyrighted. Copying our publications in whole or in part, for whatever
reason, is a violation of copyrights laws and can lead to penalties and fines.

Should you want to copy tables, graphs or other materials from our publications, please contact us to request
permission. ICON Group Ltd. often grants permission for very limited reproduction of our publications for internal
use, press releases, and academic research. Such reproduction requires, however, confirmed permission from ICON
Group Ltd. Please read the full copyright notice, disclaimer, and user agreement provisions at the end of this
report.




                                          IMPORTANT DISCLAIMER



Neither ICON Group Ltd. nor its employees can be held accountable for the use and subsequent actions of the user of
the information provided in this publication. Great efforts have been made to ensure the accuracy of the data, but we
can not guarantee, given the volume of information, accuracy. Since the information given in this report is
forward-looking, the reader should read the disclaimer statement and user agreement provisions at the end of
this report.




www.icongrouponline.com                                                                   ©2011 ICON Group Ltd.
                                                                                              iv


                                About the Author
Dr. Philip M. Parker is the Eli Lilly Chaired Professor of Innovation, Business and Society at
INSEAD where he has taught courses on multivariate statistics and global competitive strategy
since 1988. He has also taught courses at MIT, Stanford University, Harvard University, UCLA,
UCSD, and the Hong Kong University of Science and Technology. He is the author of six books
on the economic convergence of nations. These books introduce the notion of “physioeconomics”
which foresees a lack of global convergence in economic behaviors due to physiological and
physiographic forces. His latest book is "Physioeconomics: The Basis for Long-Run Economic
Growth" (MIT Press 2000). He has also published numerous articles in academic journals,
including The Rand Journal of Economics, Marketing Science, the Journal of International
Business Studies, Technological Forecasting and Social Change, International Journal of
Forecasting, the European Management Journal, the European Journal of Operational
Research, Journal of Marketing, International Journal of Research in Marketing, and Journal of
Marketing Research. He is also on the editorial boards of several academic journals.

Dr. Parker received his Ph.D. in Business Economics from the Wharton School of the University
of Pennsylvania and has Masters degrees in Finance and Banking (University of Aix-Marseille)
and Managerial Economics (Wharton). His undergraduate degrees are in mathematics, biology
and economics (minor in aeronautical engineering). He has consulted and/or taught courses in
Africa, the Middle East, Asia, Latin America, North America and Europe.



                                 About this Series
This series was created for international firms who rely on foreign export markets for a
substantial portion of their business or who might be threatened by foreign trade competition.
The estimates given in this report were created using a methodology developed by and under the
direct supervision of Professor Philip M. Parker, the Eli Lilly Chaired Professor of Innovation,
Business and Society, at INSEAD. The methodology, relying on historical figures of economic
growth and trade flows, estimates the market shares of some 150 countries for over 500 industrial
or product categories. The figures should be seen as market estimates, as opposed to historical
records, as these are projected for the current year of trade.



                               Acknowledgements
Some of the methodologies and research approaches used in this report have benefited from the
R&D Committee at INSEAD, whose research support is gratefully acknowledged. Additional
editorial assistance from Tiffany LaRochelle, ICON Group International, Inc., is also
acknowledged.



www.icongrouponline.com                                                    ©2011 ICON Group Ltd.
                                                                                                    v


                           About ICON Group Ltd.
ICON Group Ltd.’s primary mission is to assist managers with their international information
needs. U.S.-owned and operated, ICON Group has field offices in Paris, Hong Kong and Lomé,
Togo (West Africa). Created in 1994, ICON Group has published hundreds of multi-client
databases, and global/regional market data, industry and country publications.

Global/Regional Management Studies. Summarizing over 190 countries, management studies
are generally organized into regional volumes and cover key management functions. The human
resource series covers minimum wages, child labor, unionization and collective bargaining. The
international law series covers media control and censorship, search and seizure, and trial justice
and punishment. The diversity management series covers a variety of environmental context
drivers that effect global operations. These include women’s rights, children’s rights,
discrimination/racism, and religious forces and risks. Global strategic planning studies cover
economic risk assessments, political risk assessments, foreign direct investment strategy,
intellectual property strategy, and export strategies. Financial management studies cover taxes
and tariffs. Global marketing studies focus on target segments (e.g. seniors, children, women) and
strategic marketing planning.

Country Studies. Often managers need an in-depth, yet broad and up-to-date understanding of a
country’s strategic market potential and situation before the first field trip or investment proposal.
There are over 190 country studies available. Each study consists of analysis, statistics, forecasts,
and information of relevance to managers. The studies are continually updated to insure that the
reports have the most relevant information available. In addition to raw information, the reports
provide relevant analyses which put a more general perspective on a country (seen in the context
of relative performance vis-à-vis benchmarks).

Industry Studies. Companies are racing to become more international, if not global in their
strategies. For over 2000 product/industry categories, these reports give the reader a concise
summary of latent market forecasts, pro-forma financials, import competition profiles, contacts,
key references and trends across 200 countries of the world. Some reports focus on a particular
product and region (up to four regions per product), while others focus on a product within a
particular country.

                               Orders & Customer Service
                               ICON Group International, Inc.
                               7404 Trade St.
                               San Diego, CA 92121
                               USA
                               Tel: (858) 635 9410
                               Fax: (858) 635 9414
                               E-mail: orders@icongroupbooks.com
                               www.icongrouponline.com

www.icongrouponline.com                                                       ©2011 ICON Group Ltd.
                                                      Contents        vi


Table of Contents
1     INTRODUCTION AND METHODOLOGY                                8
2     NEW ZEALAND AND THE WORLD MARKET                           10
    2.1        Imports in New Zealand in 2011                    10
    2.2        Exports from New Zealand in 2011                  11
3     IMPORTS IN NEW ZEALAND                                     12
    3.1        Asia                                              12
       3.1.1      China                                          12
       3.1.2      India                                          13
       3.1.3      Japan                                          14
       3.1.4      Malaysia                                       15
       3.1.5      Philippines                                    15
       3.1.6      Singapore                                      16
       3.1.7      Taiwan                                         16
       3.1.8      Thailand                                       17
    3.2        Europe                                            18
       3.2.1      Denmark                                        18
       3.2.2      Estonia                                        19
       3.2.3      Ireland                                        20
       3.2.4      Spain                                          21
       3.2.5      the Netherlands                                22
    3.3        Latin America                                     23
       3.3.1      Argentina                                      23
    3.4        North America & the Caribbean                     24
       3.4.1      Canada                                         24
       3.4.2      the United States                              25
    3.5        Oceana                                            26
       3.5.1      Australia                                      26
    3.6        the Middle East                                   27
       3.6.1      Turkey                                         27
4     EXPORTS FROM NEW ZEALAND                                   28
    4.1        Africa                                            28
       4.1.1      South Africa                                   28
    4.2        Asia                                              29
       4.2.1      Hong Kong                                      29
       4.2.2      Singapore                                      30
       4.2.3      South Korea                                    31
       4.2.4      Thailand                                       32
    4.3        Europe                                            33
       4.3.1      Denmark                                        33
       4.3.2      Slovenia                                       34
    4.4        Latin America                                     35
       4.4.1      Guatemala                                      35
    4.5        North America & the Caribbean                     36
       4.5.1      Canada                                         36
    4.6        Oceana                                            37
       4.6.1      Australia                                      37
       4.6.2      Fiji                                           38
    4.7        the Middle East                                   39


www.icongrouponline.com                           ©2011 ICON Group Ltd.
                                                              Contents        vii

      4.7.1     Jordan                                                   39
      4.7.2     Saudi Arabia                                             40
5     DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS             41
    5.1       Disclaimers & Safe Harbor                                  41
    5.2       ICON Group Ltd. User Agreement Provisions                  42




www.icongrouponline.com                                   ©2011 ICON Group Ltd.
 Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and
Streptomycins in New Zealand                                                                  8


1       INTRODUCTION AND METHODOLOGY
On the demand side, exporters and strategic planners focusing on medicaments containing
antibiotics in dosage form or retail packings excluding penicillins and streptomycins in New
Zealand face a number of questions. Which countries are supplying medicaments containing
antibiotics in dosage form or retail packings excluding penicillins and streptomycins to New
Zealand? How important is New Zealand compared to others in terms of the entire global and
regional market? How much do the imports of medicaments containing antibiotics in dosage
form or retail packings excluding penicillins and streptomycins vary from one country of origin
to another in New Zealand? On the supply side, New Zealand also exports medicaments
containing antibiotics in dosage form or retail packings excluding penicillins and streptomycins.
Which countries receive the most exports from New Zealand? How are these exports
concentrated across buyers? What is the value of these exports and which countries are the
largest buyers?

This report was created for strategic planners, international marketing executives and
import/export managers who are concerned with the market for medicaments containing
antibiotics in dosage form or retail packings excluding penicillins and streptomycins in New
Zealand. With the globalization of this market, managers can no longer be contented with a local
view. Nor can managers be contented with out-of-date statistics which appear several years after
the fact. I have developed a methodology, based on macroeconomic and trade models, to
estimate the market for medicaments containing antibiotics in dosage form or retail packings
excluding penicillins and streptomycins for those countries serving New Zealand via exports, or
supplying from New Zealand via imports. It does so for the current year based on a variety of
key historical indicators and econometric models.

In what follows, Chapter 2 begins by summarizing where New Zealand fits into the world market
for imported and exported medicaments containing antibiotics in dosage form or retail packings
excluding penicillins and streptomycins. The total level of imports and exports on a worldwide
basis, and those for New Zealand in particular, is estimated using a model which aggregates
across over 150 key country markets and projects these to the current year. From there, each
country represents a percent of the world market. This market is served from a number of
competitive countries of origin. Based on both demand- and supply-side dynamics, market shares
by country of origin are then calculated across each country market destination. These shares
lead to a volume of import and export values for each country and are aggregated to regional and
world totals. In doing so, we are able to obtain maximum likelihood estimates of both the value
of each market and the share that New Zealand is likely to receive this year. From these figures,
rankings are calculated to allow managers to prioritize New Zealand compared to other major
country markets. In this way, all the figures provided in this report are forecasts that can be
combined with internal information sources for strategic planning purposes.

After the worldwide summary in Chapter 2 of both imports and exports of medicaments
containing antibiotics in dosage form or retail packings excluding penicillins and streptomycins,

www.icongrouponline.com                                                          ©2011 ICON Group Ltd.
 Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and
Streptomycins in New Zealand                                                                  9

Chapter 3 goes into detail on imports, but for each major country of origin serving New Zealand.
A “major” market is defined as a country where New Zealand represents a substantially large
share of either imports or exports. For each major country exporting to New Zealand, one can
thus observe how important New Zealand is to that exporting country compared to other
countries of the world. Chapter 4 does the same, but for exports of medicaments containing
antibiotics in dosage form or retail packings excluding penicillins and streptomycins originating
from New Zealand, for each major country of destination. In doing so, one can discover the share
that New Zealand has in each major market; this share value is often used as a measure of
competitiveness for New Zealand. In all cases, the total dollar volume and percentage share
values by major trading partner are provided. Combined, Chapters 3 and 4 present a the total
picture for imports and exports of medicaments containing antibiotics in dosage form or retail
packings excluding penicillins and streptomycins to and from New Zealand to and from all other
major countries in the world. "Medicaments Containing Antibiotics in Dosage Form or Retail
Packings Excluding Penicillins and Streptomycins" as a category is defined in this report
following the definition given by the United Nations Statistics Division Classification Registry
using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code
that defined "medicaments containing antibiotics in dosage form or retail packings excluding
penicillins and streptomycins" is 54219 . For more information on this definition, please refer to
the following web site:
http://unstats.un.org/unsd/cr/registry/regcs.asp?Cl=14&Lg=1&Co=542 .

This report is updated on an annual basis. To ensure that you have the most current version,
please check the web site of ICON Group at www.icongrouponline.com.

Important Caveat. The figures should be seen as market estimates, as opposed to historical
records, as these are forecasted for the current year of trade. More importantly, in light of the fact
that unforeseeable factors might interrupt markets in achieving their reported levels, the figures
should be seen as estimates of potential. For example, "mad cow" disease, foot-and-mouth
disease, trade embargoes, military conflicts, acts of terrorism and other events will certainly
affect the actual trade flows recorded for a variety of industry or product categories. In such
cases, the difference between the numbers given in this report and the numbers actually observed
might be interpreted as the "net loss" or "net gain" due to these exogenous events affecting
regular trade flows that would have occurred had these events not have taken place.




www.icongrouponline.com                                                          ©2011 ICON Group Ltd.
 Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and
Streptomycins in New Zealand                                                                 10


2       NEW ZEALAND AND THE WORLD MARKET
2.1         IMPORTS IN NEW ZEALAND IN 2011
 Imported Medicaments Containing Antibiotics in Dosage Form or Retail Packings
           Excluding Penicillins and Streptomycins in New Zealand, 2011
                              (Structure of Foreign Import Competition)

Country of Origin             Rank         Value (000 US$)              % Share        Cumulative %
_________________________________________________________________________________________________________
Australia                         1                     6,748               24.90                  24.90
Ireland                           2                     6,585               24.30                  49.21
Italy                             3                     2,692                9.94                  59.14
the United States                 4                     2,120                7.82                  66.97
the Netherlands                   5                     1,912                7.06                  74.02
Belgium                           6                     1,224                4.52                  78.54
Spain                             7                       890                3.28                  81.82
India                             8                       836                3.09                  84.91
Canada                            9                       787                2.90                  87.81
Germany                          10                       769                2.84                  90.65
France                           11                       558                2.06                  92.71
Denmark                          12                       402                1.48                  94.19
Japan                            13                       380                1.40                  95.60
Philippines                      14                       364                1.34                  96.94
Taiwan                           15                       253                0.93                  97.87
Malaysia                         16                       216                0.80                  98.67
China                            17                       146                0.54                  99.21
Turkey                           18                       112                0.41                  99.62
Argentina                        19                        44                0.16                  99.79
Thailand                         20                        33                0.12                  99.91
Estonia                          21                        18                0.07                  99.97
Singapore                        22                         7                0.03                 100.00
Total                                                  27,096              100.00                 100.00
_________________________________________________________________________________________________________
    Source: Philip M. PARKER, Professor, INSEAD, copyright 2011, www.icongrouponline.com




www.icongrouponline.com                                                          ©2011 ICON Group Ltd.
 Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding Penicillins and
Streptomycins in New Zealand                                                                 11


2.2         EXPORTS FROM NEW ZEALAND IN 2011
 Medicaments Containing Antibiotics in Dosage Form or Retail Packings Excluding
          Penicilli
								
To top